Stratford Consulting’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$207K Buy
2,715
+22
+0.8% +$1.87K 0.09% 52
2019
Q4
$238K Buy
2,693
+22
+0.8% +$1.83K 0.08% 52
2019
Q3
$202K Buy
+2,671
New +$183K 0.07% 53
2019
Q2
Sell
-2,565
Closed -$207K 56
2019
Q1
$207K Buy
2,565
+27
+1% +$2.21K 0.07% 51
2018
Q4
$234K Buy
2,538
+22
+0.9% +$1.94K 0.09% 49
2018
Q3
$238K Sell
2,516
-646
-20% -$61.3K 0.08% 45
2018
Q2
$293K Buy
3,162
+23
+0.7% +$2.25K 0.11% 41
2018
Q1
$297K Sell
3,139
-279
-8% -$30.6K 0.11% 40
2017
Q4
$331K Buy
3,418
+19
+0.6% +$1.79K 0.12% 41
2017
Q3
$302K Buy
3,399
+25
+0.7% +$1.9K 0.11% 41
2017
Q2
$245K Sell
3,374
-585
-15% -$39.3K 0.1% 39
2017
Q1
$258K Buy
3,959
+29
+0.7% +$1.82K 0.1% 45
2016
Q4
$246K Buy
3,930
+24
+0.6% +$1.47K 0.11% 46
2016
Q3
$246K Sell
3,906
-872
-18% -$56.5K 0.11% 44
2016
Q2
$296K Sell
4,778
-770
-14% -$46.9K 0.13% 41
2016
Q1
$317K Buy
5,548
+37
+0.7% +$2.06K 0.15% 41
2015
Q4
$326K Buy
5,511
+29
+0.5% +$1.67K 0.17% 44
2015
Q3
$298K Buy
5,482
+26
+0.5% +$1.69K 0.16% 43
2015
Q2
$367K Sell
5,456
-459
-8% -$30K 0.18% 39
2015
Q1
$346K Sell
5,915
-245
-4% -$14.8K 0.17% 44
2014
Q4
$403K Sell
6,160
-64
-1% -$4.04K 0.21% 40
2014
Q3
$360K Buy
6,224
+32
+0.5% +$1.78K 0.19% 42
2014
Q2
$349K Buy
6,192
+32
+0.5% +$1.68K 0.18% 42
2014
Q1
$317K Buy
6,160
+28
+0.5% +$1.42K 0.17% 43
2013
Q4
$324K Buy
6,132
+29
+0.5% +$1.43K 0.18% 43
2013
Q3
$273K Buy
6,103
+37
+0.6% +$1.64K 0.17% 43
2013
Q2
$251K Buy
+6,066
New +$265K 0.15% 43

Other funds holding ABBV